<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-08000R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0005034</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Gene Expression</subject><subject>Developmental Biology/Stem Cells</subject><subject>Genetics and Genomics/Animal Genetics</subject><subject>Genetics and Genomics/Gene Expression</subject><subject>Genetics and Genomics/Gene Function</subject><subject>Molecular Biology/Transcription Elongation</subject><subject>Molecular Biology/Transcription Initiation and Activation</subject></subj-group></article-categories><title-group><article-title>Mouse Cofactor of BRCA1 (Cobra1) Is Required for Early Embryogenesis</article-title><alt-title alt-title-type="running-head">Cobra1 KO Is Embryonic Lethal</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Amleh</surname><given-names>Asma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Nair</surname><given-names>Sreejith J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Jianlong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sutherland</surname><given-names>Ann</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hasty</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Rong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Molecular Medicine, Institute of Biotechnology, University of Texas, Health Science Center at San Antonio, San Antonio, Texas, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Cell Biology, University of Virginia School of Medicine, Charlottesville, Virginia, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sham</surname><given-names>Mai Har</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">The University of Hong Kong, China</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>lir3@uthscsa.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: AA SJN RL. Performed the experiments: AA SJN JS. Analyzed the data: AA SJN JS AS PH RL. Contributed reagents/materials/analysis tools: AS PH. Wrote the paper: AA RL.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>2</day><month>4</month><year>2009</year></pub-date><volume>4</volume><issue>4</issue><elocation-id>e5034</elocation-id><history><date date-type="received"><day>3</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>26</day><month>2</month><year>2009</year></date></history><copyright-statement>Amleh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><sec><title>Background</title><p>Negative elongation factor (NELF) is a four-subunit protein complex conserved from <italic>Drosophila</italic> to humans. <italic>In vitro</italic> biochemical and tissue culture-based studies have demonstrated an important role of NELF in controlling RNA polymerase II (Pol II) pausing in transcription. However, the physiological significance of NELF function is not clear due to the lack of any genetic systems for studying NELF.</p></sec><sec><title>Principal Findings</title><p>Here we show that disruption of the mouse B subunit of NELF (NELF-B), also known as <italic>cofactor of BRCA1</italic> (<italic>Cobra1</italic>), causes inner cell mass (ICM) deficiency and embryonic lethality at the time of implantation. Consistent with the phenotype of the <italic>Cobra1</italic> knockout (KO) embryos, knockdown of Cobra1 in mouse embryonic stem cells (ESCs) reduces the efficiency of colony formation and increases spontaneous differentiation. <italic>Cobra1</italic>-depleted ESCs maintain normal levels of <italic>Oct4</italic>, <italic>Nanog</italic>, and <italic>Sox2</italic>, master regulators of pluripotency in ESCs. However, knockdown of Cobra1 leads to precocious expression of developmental regulators including <italic>lymphoid enhancer-binding factor 1</italic> (<italic>Lef1</italic>). Chromatin immunoprecipitation (ChIP) indicates that Cobra1 binds to the <italic>Lef1</italic> promoter and modulates the abundance of promoter-bound RNA polymerase.</p></sec><sec><title>Conclusions</title><p><italic>Cobra1</italic> is essential for early embryogenesis. Our findings also indicate that <italic>Cobra1</italic> helps maintain the undifferentiated state of mESCs by preventing unscheduled expression of developmental genes.</p></sec></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Inner cell mass (ICM) of the blastocysts is a cluster of cells that gives rise to all the cells of the body. ESCs, which are <italic>in vitro</italic> derivatives of the ICM, maintain the capacity of self-renewal and multi-lineage differentiation. Maintenance of pluripotency or choice of differentiation in both ICM and ESCs is dictated by a transcriptional regulatory circuitry that is composed of a plethora of transcription factors and signal transduction pathways <xref ref-type="bibr" rid="pone.0005034-Surani1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Jaenisch1">&#x0005b;2&#x0005d;</xref>. At the center of the regulatory circuitry are three DNA-binding transcription factors, <italic>Oct4</italic>, <italic>Nanog</italic>, and <italic>Sox2</italic>. These master regulators can coordinately control the expression of two different categories of target genes in ESCs <xref ref-type="bibr" rid="pone.0005034-Boyer1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Loh1">&#x0005b;4&#x0005d;</xref>. The first group is activated by the master regulators and is essential for the establishment and maintenance of pluripotency of ESCs. In addition, <italic>Oct4/Nanog/Sox2</italic> repress the expression of a number of developmental genes in order to maintain the undifferentiated state of ESCs. How the master regulators exert the opposing actions on these two types of target genes is not well understood. However, it has been recently shown that most silenced developmental genes are organized in chromatin domains that contain histone modification markers for both transcriptional activation and repression <xref ref-type="bibr" rid="pone.0005034-Azuara1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005034-Guenther1">&#x0005b;7&#x0005d;</xref>, leading to the notion that the unique chromatin structure helps maintain a silenced yet poised transcriptional state at these loci and renders prompt gene activation in response to developmental cues. Consistent with this notion, Polycomb group (PcG) proteins, which induce condensed chromatin structure, have been implicated in transcriptional repression of developmental genes in ESCs <xref ref-type="bibr" rid="pone.0005034-Boyer2">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Lee1">&#x0005b;9&#x0005d;</xref>.</p><p>Cofactor of BRCA1 (COBRA1) was first identified as a BRCA1-interacting protein and subsequently found to be the B subunit of the negative elongation factor complex (NELF-B) <xref ref-type="bibr" rid="pone.0005034-Ye1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Narita1">&#x0005b;11&#x0005d;</xref>. The four-subunit NELF complex was biochemically purified based on its ability <italic>in vitro</italic> to stall RNA polymerase II (RNAPII) in cooperation with the DRB sensitivity-inducing factor (DSIF) at an early stage of transcription elongation <xref ref-type="bibr" rid="pone.0005034-Yamaguchi1">&#x0005b;12&#x0005d;</xref>. Consistent with <italic>in vitro</italic> findings, tissue culture work indicates that human NELF and its <italic>Drosophila</italic> ortholog can induce transcriptional pausing and attenuate transcription elongation <xref ref-type="bibr" rid="pone.0005034-Aiyar1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Wu1">&#x0005b;14&#x0005d;</xref>. However, recent whole-genome studies indicate that NELF can also positively regulate a large number of genes in human and flies <xref ref-type="bibr" rid="pone.0005034-Aiyar2">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005034-Narita2">&#x0005b;17&#x0005d;</xref>. Despite the extensive biochemical and cell culture-based studies, genetic evidence for the physiological importance of COBRA1/NELF is lacking. Using a conditional knockout (KO) mouse model for <italic>Cobra1</italic>, we demonstrate a critical role of <italic>Cobra1</italic> in early embryonic development. Further characterization of <italic>Cobra1</italic> in mouse ESCs indicates that <italic>Cobra1</italic> plays an important role in maintaining the undifferentiated state of ESCs.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Whole body deletion of mouse Cobra1 results in embryonic lethality</title><p>To investigate the <italic>in vivo</italic> function of <italic>Cobra1</italic>, we generated a conditional KO mouse by bracketing the putative promoter and the first four exons of the gene with loxP sites (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1A</xref>). One <italic>floxed-Cobra1</italic> allele in both somatic and germ cells was converted to a null allele by whole-body Cre-mediated recombination (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1B</xref> and <xref ref-type="supplementary-material" rid="pone.0005034.s001">Fig. S1A</xref>). Heterozygous <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> mice appeared to develop normally. They were fertile and had a normal life span. In multiple adult tissues tested, <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> mice produced approximately half the amount of <italic>Cobra1</italic> mRNA and protein that their wild-type littermates did (<xref ref-type="supplementary-material" rid="pone.0005034.s001">Fig. S1B and S1C</xref>; data not shown). A similar result was observed with the <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>Cobra1<sup>&#x0002b;/&#x0002b;</sup></italic> embryos (<xref ref-type="supplementary-material" rid="pone.0005034.s001">Fig. S1D</xref>).</p><fig id="pone-0005034-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005034.g001</object-id><label>Figure 1</label><caption><title><italic>Cobra1</italic> is essential for early embryonic development.</title><p>A. Illustration of the wild type <italic>Cobra1</italic> locus (top) and a portion of the targeting construct (bottom). The short (left) and long (right) homology arms encompass genomic regions 1.1 kb upstream of exon 1 and &#x0223c;8.4 kb downstream of exon 4, respectively. Also indicated are loxP (red arrows), FRT sites (crescents), exons (open bars), BamH1 sites (B), promoter (solid arrow), 5&#x02032; probe (blue bar), and PCR primers (block arrows). B. Southern blot for the BamH1-digested genomic DNA from 3 wk old pups of Cobra1<sup>&#x0002b;/&#x02212;</sup> intercross. C. Summary of the genotypes from the <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> intercrosses. D and E. Phenotype of <italic>Cobra1<sup>&#x0002b;/&#x0002b;</sup></italic> (D) and <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> (E) embryos retrieved at E8 of embryonic development. The block arrows point to embryo proper.</p></caption><graphic xlink:href="pone.0005034.g001"/></fig><p>Intercrossing of <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> did not yield any viable progeny that were homozygous for the deletion (3 weeks; <xref ref-type="fig" rid="pone-0005034-g001">Fig. 1C</xref>), clearly indicating an essential role of <italic>Cobra1</italic> in embryonic development. To determine the developmental stage at which <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos were lost, embryos from timed mating of <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> were retrieved on various days post-coitum (dpc). Only one out of 45 embryos examined at 10&#x02013;13.5 dpc was <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic>, whereas 2 out of 16 embryos at 8&#x02013;9 dpc and 11 out of 44 embryos at 6&#x02013;7.5 dpc carried both deletion alleles (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1C</xref>). Notably, a significant percentage of embryos were reabsorbed, possibly due to homozygous deletion of <italic>Cobra1</italic>. It should be noted that, while we were able to retrieve <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryonic materials between 6 and 13.5 dpc, no <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos developed beyond &#x0223c;E5 (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1E</xref>). In contrast, wild-type and heterozygous deletion embryos reached the expected developmental age at the time of retrieval (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1D</xref>). Occasionally, we came across <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> embryos that were retarded in development. Taken together, our results clearly demonstrate an essential role for <italic>Cobra1</italic> during early embryonic development.</p><p>Human COBRA1 interacts with BRCA1 <xref ref-type="bibr" rid="pone.0005034-Ye1">&#x0005b;10&#x0005d;</xref>, and the two proteins regulate transcription of a number of genes in concert <xref ref-type="bibr" rid="pone.0005034-Aiyar2">&#x0005b;15&#x0005d;</xref>. Because early embryonic lethality of whole-body <italic>Brca1</italic> KO can be delayed by p53 mutation <xref ref-type="bibr" rid="pone.0005034-Moynahan1">&#x0005b;18&#x0005d;</xref>, we sought to determine whether the same were true for <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos. <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup>; p53<sup>&#x0002b;/&#x02212;</sup></italic> compound mice were generated and inter-crossed <xref ref-type="bibr" rid="pone.0005034-Donehower1">&#x0005b;19&#x0005d;</xref>. No viable <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> mice in the <italic>p53<sup>&#x0002b;/&#x02212;</sup></italic> or <italic>p53<sup>&#x02212;/&#x02212;</sup></italic> mutant background were found (<xref ref-type="supplementary-material" rid="pone.0005034.s002">Fig. S2</xref>). There was no sign of partial rescue by the p53 mutation of <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos beyond E5.5 either (data not shown). Therefore, activation of the p53-mediated checkpoint was an unlikely contributing factor to the lethality associated with the <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos.</p></sec><sec id="s2b"><title><italic>Cobra1</italic> deletion results in poorly developed inner cell mass</title><p>To determine whether <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos at the pre-implantation stage were competent for development, we retrieved embryos at the two-cell stage and cultured them <italic>in vitro</italic> until the blastocyst stage. Approximately 90&#x00025; of the embryos reached the blastocyst stage while the remaining 10&#x00025; either stayed at the two-cell stage or resulted in fragmented embryos (data not shown). All three <italic>Cobra1</italic> genotypes were represented in the embryos that developed to the blastocyst stage at the expected Mendelian ratio (E3.5; <xref ref-type="fig" rid="pone-0005034-g001">Fig. 1C</xref>). Furthermore, the <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> blastocysts were morphologically indistinguishable from the wild-type counterparts (<xref ref-type="fig" rid="pone-0005034-g002">Fig. 2A</xref>). These results indicate that <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos are competent for pre-implantation development and the defect in embryogenesis could lie at a later stage.</p><fig id="pone-0005034-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005034.g002</object-id><label>Figure 2</label><caption><title>Impaired outgrowth of <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> blastocysts.</title><p>A. <italic>In vitro</italic> developed blastocysts (<italic>Cobra1<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic>) from two-cell stage embryos. B. <italic>Cobra1</italic> deletion resulted in elevated incidence of outgrowths with defective or no ICM derivatives. C&#x02013;D. Normal (<italic>Cobra<sup>&#x0002b;/&#x0002b;</sup></italic>; C) and defective (<italic>Cobra<sup>&#x02212;/&#x02212;</sup></italic>; D) blastocyst outgrowth four days after <italic>in vitro</italic> culture. The ICM derivatives (&#x0002a;) and trophoblast giant cells (TGC) are indicated.</p></caption><graphic xlink:href="pone.0005034.g002"/></fig><p>The fact that the majority of the embryos fail to proceed to the post-implantation stages could be due to either a defect in hatching from the zona pellucida or a deficiency intrinsic to the ICM in forming the embryo proper. To distinguish these possibilities, we allowed blastocysts from the <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> intercrosses to form outgrowths in culture. The majority of blastocysts (94&#x00025;) successfully hatched from the zona pellucida (data not shown). After 4 days in culture, all blastocysts produced trophoblast giant cell (TGC) outgrowths but not all contained a discernable ICM. As shown in <xref ref-type="fig" rid="pone-0005034-g002">Fig. 2B and 2C</xref>, <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> blastocysts produced a significantly larger number of outgrowths with poorly developed or no ICM than their wild-type and heterozygous counterparts. <italic>Cobra1</italic> deficiency does not appear to affect cell proliferation of the outgrowths, as outgrowths of all three genotypes incorporated the comparable extent of BrdU (<xref ref-type="supplementary-material" rid="pone.0005034.s003">Fig. S3</xref>). Furthermore, the high rate of abnormal outgrowths associated with <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> blastocysts is unlikely due to delayed growth, because longer periods of <italic>in vitro</italic> culturing (up to 7 days) did not improve the percentage of normal outgrowths from the <italic>Cobra1<sup>&#x02212;/&#x02212;</sup></italic> embryos (data not shown). These findings suggest that <italic>Cobra1</italic> may play an important role in establishment and/or maintenance of the ICM.</p></sec><sec id="s2c"><title><italic>Cobra1</italic> knockdown impairs the undifferentiated state of mouse embryonic stem cells</title><p>To better understand the molecular and cellular basis for the function of <italic>Cobra1</italic> in early embryonic development, we examined the role of <italic>Cobra1</italic> in mouse embryonic stem cells (ESCs). As shown in <xref ref-type="fig" rid="pone-0005034-g003">Fig. 3A</xref>, siRNA-mediated knockdown significantly depleted ESCs of endogenous Cobra1 protein. Interestingly, levels of all three master regulators (<italic>Oct4</italic>, <italic>Nanog</italic>, and <italic>Sox2</italic>) remained unchanged in the <italic>Cobra1</italic>-knockdown ESCs (<xref ref-type="fig" rid="pone-0005034-g003">Fig. 3A</xref>). Compared with the control ESCs (<xref ref-type="fig" rid="pone-0005034-g003">Fig. 3B and 3C</xref>), <italic>Cobra1</italic>-depleted ESCs displayed reduced efficiency of colony formation (<xref ref-type="fig" rid="pone-0005034-g003">Fig. 3D&#x02013;3E</xref>; also see quantitation in <xref ref-type="fig" rid="pone-0005034-g003">Fig. 3F</xref>). Proliferation rates of the <italic>Cobra1</italic>-knockdown cells were only modestly reduced (<xref ref-type="supplementary-material" rid="pone.0005034.s004">Fig. S4</xref>), making it an unlikely cause for the reduced efficiency of colony formation. Concomitant with the impaired colony formation, <italic>Cobra1</italic>-knockdown cells tended to form monolayers of loosely associated cells with a fibroblastic morphology (compare <xref ref-type="fig" rid="pone-0005034-g003">Fig. 3G and 3H</xref>). Furthermore, Cobra1-knockdown cells displayed diminished staining for alkaline phosphatase (AP), an established marker for ESC (<xref ref-type="fig" rid="pone-0005034-g003">Fig. 3G&#x02013;3I</xref>). These findings suggest that <italic>Cobra1</italic> helps maintain the undifferentiated state of mESCs.</p><fig id="pone-0005034-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005034.g003</object-id><label>Figure 3</label><caption><title>Cobra1 knockdown in mouse ESCs results in reduced colony formation and increased spontaneous differentiation.</title><p>A. Knockdown of Cobra1 by siRNA does not affect protein levels of Oct4, Nanog, or Sox2. B&#x02013;E. Cobra1 knockdown reduces the colony formation capability of mESCs. F. Quantitation of the colony formation efficiency in B&#x02013;E. The value for the mock-transfected cells is set at 1. G&#x02013;H. Representatives of AP-stained undifferentiated (G) and differentiated (H) ESC colonies. I. Quantitation of the percentage of differentiated colonies.</p></caption><graphic xlink:href="pone.0005034.g003"/></fig></sec><sec id="s2d"><title><italic>Cobra1</italic> depletion increases the expression of development-associated genes</title><p>Given the well-documented transcriptional regulatory activity of NELF, we conducted a microarray experiment using ESCs that were transiently transfected with either control or <italic>Cobra1</italic>-specific siRNA oligos. Using a fold change of 1.5 (log<sub>2</sub>) and p value of 0.05 as the cutoff, we identified a total of 334 and 403 up- and down-regulated genes, respectively, in the Cobra1-knockdown cells (<xref ref-type="supplementary-material" rid="pone.0005034.s006">Table S1</xref>). Gene ontology (GO) analysis indicates that developmental genes are over-represented among the up-regulated genes in Cobra1-knockdown cells (<xref ref-type="supplementary-material" rid="pone.0005034.s005">Fig. S5</xref>). Interestingly, a significant number of the developmental genes have been previously shown to be occupied by at least one of the three master pluripotency regulators <xref ref-type="bibr" rid="pone.0005034-Boyer1">&#x0005b;3&#x0005d;</xref> (<xref ref-type="supplementary-material" rid="pone.0005034.s007">Table S2</xref>).</p><p>Lymphoid enhancer-binding factor 1 (<italic>Lef1</italic>), a key transcription factor in the Wnt-mediated signal transduction pathway <xref ref-type="bibr" rid="pone.0005034-Hoppler1">&#x0005b;20&#x0005d;</xref>, was identified by the microarray study as the most significantly up-regulated developmental genes in the <italic>Cobra1</italic>-knockdown cells. We verified the effect of <italic>Cobra1</italic> knockdown on <italic>Lef1</italic> mRNA by quantitative RT-PCR using two independent <italic>Cobra1</italic> siRNA oligos (<xref ref-type="fig" rid="pone-0005034-g004">Fig. 4A and 4B</xref>). Furthermore, chromatin immunoprecipitation (ChIP) demonstrates a physical association of Cobra1 with the <italic>Lef1</italic> promoter region (<xref ref-type="fig" rid="pone-0005034-g004">Fig. 4C</xref>), suggesting a direct impact of Cobra1 on <italic>Lef1</italic> transcription. To ascertain the involvement of <italic>Cobra1</italic> in modulation of <italic>Lef1</italic> mRNA synthesis, Pol II ChIP was conducted in control and Cobra1-knockdown ESCs. As shown in <xref ref-type="fig" rid="pone-0005034-g004">Fig. 4D</xref>, the amount of Pol II at both the promoter and first exon of the <italic>Lef1</italic> gene was substantially elevated in <italic>Cobra1</italic>-knockdown cells, suggesting that Cobra1 modulates the presence of Pol II at the promoter-proximal region of the <italic>Lef1</italic> gene.</p><fig id="pone-0005034-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005034.g004</object-id><label>Figure 4</label><caption><title>Cobra1 is required for transcriptional repression of <italic>Lef1</italic> in ESCs.</title><p>A. Real-time RT-PCR of <italic>Cobra1</italic> mRNA in control and <italic>Cobra1</italic>-knockdown cells 3 and 6 days after siRNA transfection. B. <italic>Lef1</italic> mRNA in control and <italic>Cobra1</italic>-knockdown cells. C. Cobra1 ChIP at the promoter and exon 1 of the <italic>Lef1</italic> gene in parental ESCs. Preimmune antiserum was used as the negative control. D. Pol II ChIP at the promoter and exon 1 of the <italic>Lef1</italic> locus in control and <italic>Cobra1</italic>-knockdown ESCs six days after transfection.</p></caption><graphic xlink:href="pone.0005034.g004"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>Recent studies of genome-wide transcription suggest that Pol II pausing is a highly conserved and widespread phenomenon in eukaryotes <xref ref-type="bibr" rid="pone.0005034-Kim1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005034-Zeitlinger1">&#x0005b;24&#x0005d;</xref>. Among the limited number of Pol II-pausing factors identified so far, NELF is unique in that it is only present in higher eukaryotes<xref ref-type="bibr" rid="pone.0005034-Yamaguchi1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Wada1">&#x0005b;25&#x0005d;</xref>. Studies of NELF have been predominantly focused on its biochemical and molecular function in Pol II pausing and transcriptional regulation. What is conspicuously lacking is any genetic evidence for the physiological outcomes of NELF-mediated polymerase pausing and gene regulation. To fill this gap in the knowledge of NELF, we generated a conditional mouse KO model for <italic>Cobra1/NELF-B</italic>. We demonstrate an essential role of <italic>Cobra1</italic> in early embryogenesis. Given that human COBRA1 is known to function as an integral component of the NELF complex and that levels of individual NELF subunits are interdependent <xref ref-type="bibr" rid="pone.0005034-Narita1">&#x0005b;11&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005034-Aiyar1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Narita2">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Wada1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Sun1">&#x0005b;26&#x0005d;</xref>, it is highly likely that the entire mouse NELF complex is critical for embryonic development.</p><p>Our study suggests that <italic>Cobra1</italic> facilitates the maintenance of the undifferentiated state of mESCs. One possible underlying mechanism is the <italic>Cobra1</italic>-mediated repression of development-associated genes. It remains to be determined how many of the developmental genes identified by the microarray study are direct targets of NELF and which of these potential target genes critically mediates the NELF function in ESCs. However, our data indicate that Cobra1 is physically associated with at least the promoter region of the <italic>Lef1</italic> gene. Lef1 forms heterodimers with its DNA-binding partners Tcf proteins; and the Lef1/Tcf-mediated Wnt/&#x003b2;-catenin signaling is pivotal to the functions of multipotent stem cells in the intestine, skin, and the immune system <xref ref-type="bibr" rid="pone.0005034-Reya1">&#x0005b;27&#x0005d;</xref>. Furthermore, Tcf3 co-occupies a large number of promoters with the master regulators Oct4 and Nanog in mESCs <xref ref-type="bibr" rid="pone.0005034-Cole1">&#x0005b;28&#x0005d;</xref>; and depletion of Tcf3 causes increased expression of master regulators and delayed differentiation <xref ref-type="bibr" rid="pone.0005034-Cole1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005034-Pereira1">&#x0005b;29&#x0005d;</xref>. In addition, <italic>Lef1</italic> has been implicated in trophoblast lineage differentiation of mESCs <xref ref-type="bibr" rid="pone.0005034-He1">&#x0005b;30&#x0005d;</xref>. Thus, elevated expression of <italic>Lef1</italic> in <italic>Cobra1</italic>-knockdown ESCs could contribute to the observed spontaneous differentiation in ESCs, impaired outgrowth, and early embryonic lethality.</p><p>The overt phenotype associated with <italic>Cobra1</italic> KO/knockdown is reminiscent of those associated with disruption of the master regulator genes <xref ref-type="bibr" rid="pone.0005034-Boiani1">&#x0005b;31&#x0005d;</xref>. However, unlike the master regulators, <italic>Cobra1</italic> expression is not limited to pluripotent stem cells, suggesting that its function is necessary but not sufficient for pluripotency. Within the context of ESCs, an important function of <italic>Cobra1</italic> may be to help maintain developmental genes in a repressed yet poised transcriptional state. Consistent with this notion, <italic>Cobra1</italic> depletion leads to elevated transcription of multiple developmental genes in ESCs without affecting the levels of <italic>Oct4</italic>, <italic>Nanog</italic>, or <italic>Sox2</italic>. Therefore, <italic>Cobra1</italic> most likely exerts its action in conjunction with, or independent of the master regulators. As <italic>Cobra1</italic> is not known to bind DNA by itself, it may be recruited to its target genes by the three master regulators. Alternatively, <italic>Cobra1</italic> could repress transcription through its putative interactions with other DNA-binding transcription repressors that play critical roles in ESC functions <xref ref-type="bibr" rid="pone.0005034-Dejosez1">&#x0005b;32&#x0005d;</xref>.</p><p>Recent genome-wide analyses uncovered an unexpected transcriptional and chromatin status of the developmental genes that are repressed by the master regulators in ESCs <xref ref-type="bibr" rid="pone.0005034-Guenther1">&#x0005b;7&#x0005d;</xref>. The majority of these genes experience transcription initiation, as evidenced by the presence of histone modification marks that are associated with active transcription initiation. Furthermore, Pol II can be detected at the promoter-proximal region of these transcriptionally inactive genes. The well-established biochemical function of NELF in polymerase pausing during transcription elongation would be consistent with a role of Cobra1 in keeping developmental genes in a poised transcriptional state. In this regard, it is somewhat surprising that <italic>Cobra1</italic> knockdown significantly increases the total amount of promoter-associated polymerase at the <italic>Lef1</italic> promoter-proximal region. Although it remains to be seen whether Cobra1 could regulate other putative targets in a similar fashion, our finding raises an intriguing possibility that the function of NELF may not be limited to modulation of transcription elongation.</p><p>It has been shown that NELF represses transcription of human JunB by reducing the overall polymerase density at the promoter region <xref ref-type="bibr" rid="pone.0005034-Aida1">&#x0005b;33&#x0005d;</xref>. Recent data also show that <italic>Drosophila</italic> NELF can activate transcription by preventing nucleosomal assembly in the vicinity of the transcription initiation site <xref ref-type="bibr" rid="pone.0005034-Gilchrist1">&#x0005b;16&#x0005d;</xref>. It is worth noting that approximately half of the genes in our microarray study were down-regulated by <italic>Cobra1</italic> knockdown. Further investigation of Cobra1-mediated transcription regulation in ESCs will provide a more comprehensive picture of the underlying mechanism(s) by which <italic>Cobra1</italic> contributes to the maintenance of the undifferentiated state of ESCs.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Ethics Statement</title><p>All animal procedures were approved by the Institutional Animal Care and Use Committee.</p></sec><sec id="s4b"><title>Generation of the floxed and deleted <italic>Cobra1</italic> alleles</title><p>Mice described are of mixed genetic background (C57BL/6&#x000d7;129/SvJ) unless specified. A 1.1 kb DNA fragment 5&#x02032; to exon 1 of <italic>Cobra1</italic> and 8.4 kb fragment 3&#x02032; to exon 4 were sub-cloned into a targeting vector. A loxP site was inserted 3&#x02032; to exon 4 and a <italic>loxP</italic>/<italic>FRT</italic>-flanked neomycin (neo) resistance cassette was inserted 5&#x02032; to exon 1 (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1A</xref>). The targeting construct was linearized with NotI and electroporated into iTL1 129Svev ES cells (inGenious Targeting Laboratory). DNA from antibiotic-resistant clones was digested with BamHI and subjected to Southern blot analysis. Genomic integration of the <italic>loxP</italic>-containing cassette was confirmed by PCR amplification (PCR primers A3 and N1; <xref ref-type="supplementary-material" rid="pone.0005034.s008">Table S3</xref>) and by sequencing (primer WW3). Positive clones were microinjected into C57Bl/6 blastocysts and transferred into CD-1 foster mothers. The resulting male chimeras were mated with wild-type C57Bl/6 females to test for germline transmission. F1 agouti mice were genotyped by PCR. The F1 agouti mice of <italic>Cobra1<sup>fl-neo/&#x0002b;</sup></italic> genotype were crossed with <italic>Flp-deleter</italic> transgenic mice (Stk#003946; Jackson Laboratory) to remove the Neo cassette by the FLP-mediated recombination <xref ref-type="bibr" rid="pone.0005034-Rodriguez1">&#x0005b;34&#x0005d;</xref>. The single floxed <italic>Cobra1</italic> allele was converted to a null allele by Cre-mediated recombination (EIIa-Cre) <xref ref-type="bibr" rid="pone.0005034-Lakso1">&#x0005b;35&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Embryo Recovery</title><p><italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> females were super-ovulated by intra-peritoneal injections of 5 IU of pregnant mare's serum gonadotrophin (PMSG, National Hormone &#x00026; Peptide Program, California) and 46&#x02013;48 hours later, human chorionic gonadotrophin (hCG, MP Biomedicals, Inc.). Super-ovulated females were bred with <italic>Cobra1<sup>&#x0002b;/&#x02212;</sup></italic> males. Oviducts were isolated from female mice 40&#x02013;48 hours after super-ovulation and flushed with FHM medium (Chemicon). Embryos were washed three times in FHM medium, twice in KSOM &#x0002b;AA with D-glucose (Chemicon), and incubated in KSOM droplets at 37&#x000b0;C under 5&#x00025; CO<sub>2</sub>. Droplets of KSOM were covered with embryo culture-tested mineral oil (Sigma). Blastocysts were removed from KSOM, washed with blastocyst outgrowth media <xref ref-type="bibr" rid="pone.0005034-Stephens1">&#x0005b;36&#x0005d;</xref>, and seeded separately into 24-well plates. The blastocysts outgrowths were scored 4&#x02013;5 days later, using an inverted microscope.</p></sec><sec id="s4d"><title>Genotyping</title><p>Genotypes of mice adults and embryos were identified using genomic DNA isolated from mouse-tails and whole pre-implantation embryos, respectively. DNA from tail snips was obtained by the salting-out <xref ref-type="bibr" rid="pone.0005034-Rotureau1">&#x0005b;37&#x0005d;</xref> or NaOH procedure <xref ref-type="bibr" rid="pone.0005034-ORourke1">&#x0005b;38&#x0005d;</xref>. Purified genomic DNA was digested with BamHI and subjected to Southern blot analysis, using a 1 kb probe that corresponds to a genomic region upstream of exon 1 of the <italic>Cobra1</italic> gene (<xref ref-type="fig" rid="pone-0005034-g001">Fig. 1A</xref>). To distinguish between the wild type and KO <italic>Cobra1</italic> alleles by PCR, we used a common upstream primer (CobP; <xref ref-type="supplementary-material" rid="pone.0005034.s008">Table S3</xref>) in combination with either a downstream primer specific for the wild type allele (CobWr) or the KO allele (CobNr). Due to the scarcity of the material retrieved from pre-implantation and blastocyst outgrowths, real-time PCR was used to determine the genotype of the developing embryos.</p></sec><sec id="s4e"><title>ES cell culture</title><p>Undifferentiated AB2.2 ES cells were maintained in high glucose Dulbecco's Modified Eagle's Medium (DMEM, Gibco) supplemented with 15&#x00025; fetal bovine serum (Gibco), 2 mM L-glutamine (Gibco), 0.1 mM 2-mercaptoethanol (Sigma-Aldrich), 50 U/ml penicillin, 50 &#x000b5;g/ml streptomycin (Pen-strep, Gibco), and 1000 U/ml ESGRO-LIF (Millipore). The cells were grown on 0.1&#x00025; gelatin-coated dishes.</p></sec><sec id="s4f"><title>Antibodies</title><p>The following commercially available antibodies were used in this study; Oct4 (Abcam, ab19857), Sox-2 (Santa Cruz biotechnology, sc-17320), Nanog (Bethyl laboratories, A300-397A), tubulin (Calbiochem, CP06), RNA Pol II (Abcam, ab5408). Anti-Cobra1 rabbit polyclonal antibody was generated by immunizing rabbits (Covance) with purified His-tagged Cobra1 protein. The COBRA1 monoclonal antibody used in immunoblotting has been described previously <xref ref-type="bibr" rid="pone.0005034-Aiyar1">&#x0005b;13&#x0005d;</xref>.</p></sec><sec id="s4g"><title>siRNA knockdown</title><p>Transfections with siGenome duplexes against <italic>Cobra1</italic> (Dharmacon) were performed in suspension using Lipofectamine 2000 (Invitrogen) according to manufacturer's instructions. The cells were plated in 6 well plates at a density of 4.5&#x000d7;10<sup>5</sup> cells per well. RNA was harvested for analysis 3 days after the first transfection. For the 6-day time point, cells were re-transfected with the same siRNA oligos 72 hrs after the first transfection. In all knockdown experiments siGenome non-targeting siRNA (D-001210-0X, Dharmacon) and 1&#x000d7; siRNA dilution buffer (Dharmacon) were used as negative controls.</p></sec><sec id="s4h"><title>RNA extraction, cDNA synthesis, and real-time PCR</title><p>RNA was extracted with Trizol reagent (Invitrogen). cDNA was synthesized with 1 &#x000b5;g of total RNA from ESCs using the ImPromII Reverse Transcription System (Promega) and random primers. For RNA from mouse tissues, Superscript II reverse transcriptase (Invitrogen) kit was used for cDNA synthesis. cDNA from pre-implantation embryos was obtained by using the Cells-to-cDNA II kit (Ambion) according to manufacturer's protocol. Quantitative PCR was conducted using an ABI Prism 7900 machine. Expression levels were normalized against either <italic>Gapdh</italic> (mouse tissue) or 18 s ribosomal RNA (ESCs). Results were confirmed with at least three independent experiments.</p></sec><sec id="s4i"><title>Immunoblotting</title><p>After extracting RNA from embryonic tissue samples using Trizol (Invitrogen), the organic phase was processed for DNA extraction and subsequently protein extraction. Alternatively, ESCs or frozen tissue samples were lysed and homogenized in Laemmli buffer (50 mM Tris pH 6.8, 2&#x00025; SDS, 10&#x00025; glycerol, 100 mM DTT) that contains a cocktail of protease inhibitors. Protein content was measured using the BCA Protein Assay Kit (Pierce). Immunoblotting was conducted using chemiluminescence (SuperSignal West Pico, Pierce) according to the manufacturer's instructions.</p></sec><sec id="s4j"><title>Microarray experiment, statistical analysis, and gene ontology analysis</title><p>AB2.2 cells in duplicate were transfected with control or <italic>Cobra1</italic> siRNA. Microarray was conducted by Nimblegen using a mouse 4-plex expression array (MM8 60mer expr &#x000d7;4). The data were analyzed using Genespring 9 software (Agilent Technologies). Gene ontology classification was conducted using David bioinformatics resources (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/">http://david.abcc.ncifcrf.gov/</ext-link>). Functional significance of each gene clusters were determined based on the enrichment score.</p></sec><sec id="s4k"><title>Chromatin Immunoprecipitation (ChIP)</title><p>ESCs were cross-linked with 1&#x00025; formaldehyde for 10 min, treated with glycine at a final concentration of 0.125 M for 5 min at room temperature, and lysed in lysis buffer (5 mM HEPES; pH 9.0; 85 mM KCl, 0.5&#x00025; Triton X-100) for 15 min on ice. Nuclei were resuspended in nuclei lysis buffer (50 mM Tris-HCl; pH 8.0, 10 mM EDTA; pH 8.0, 1&#x00025; SDS), and the cross-linked DNA was sonicated for 10 min (with 30 s on/off cycles) using Bioruptor (Diagenode) according to manufacturers instruction. The supernatant was used for ChIP as previously described <xref ref-type="bibr" rid="pone.0005034-Ding1">&#x0005b;39&#x0005d;</xref>.</p></sec><sec id="s4l"><title>Colony formation and alkaline phosphatase (AP) staining</title><p>ESCs were plated in triplicate on gelatin-coated 6-well plates and allowed to grow for 5 days. The colonies were stained using the StemTAG alkaline phosphatase staining kit (CBA-300; Cell Biolabs) according to manufacturer's instructions. The colonies on 10 randomly chosen fields at &#x000d7;4 magnification were counted per well and classified into undifferentiated or differentiated groups based on the morphology. The colony number for mock-transfected cells was set at 100&#x00025;. The value in the figure is mean &#x0002b;/&#x02212; standard deviation. The data were subjected to student's t-test using Sigma Plot 8.0.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0005034.s001"><label>Figure S1</label><caption><p>A. PCR-based genotyping of 3 week-old mice from Cobra1&#x0002b;/&#x02212; intercrosses. DNA samples were subjected to PCR analysis using CobP, CobWr, CobNr (see <xref ref-type="supplementary-material" rid="pone.0005034.s008">Table S3</xref>). The wild type (wt) and knockout alleles generate 350 bp and 550 bp PCR fragments, respectively. B&#x02013;C. Quantitative RT-PCR analysis of Cobra1 mRNA levels in the testicular tissue (B), ovaries (C) harvested from wt and Cobra1&#x0002b;/&#x02212; mice. D. Cobra1 immunoblot of lysates from wt and Cobra1&#x0002b;/&#x02212; embryos at E8.5.</p><p>(1.50 MB TIF)</p></caption><media xlink:href="pone.0005034.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s002"><label>Figure S2</label><caption><p>The embryonic lethality of Cobra1 knockout mice cannot be rescued by p53 mutations.</p><p>(0.92 MB TIF)</p></caption><media xlink:href="pone.0005034.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s003"><label>Figure S3</label><caption><p>Cobra1-deficient outgrowths display comparable proliferation rates as the controls. Blastocysts that had been grown in culture for three days were incubated with BrdU at 10 mM (B9285-1G; Sigma) for 12&#x02013;16 hours. Outgrowths were fixed with 4&#x00025; paraformaldehyde in phosphate buffered saline (PBS). Following cell permeablization with 0.4&#x00025; Triton X-100 for 5 min at room temperature (RT), DNA was denatured by incubation in 2 N HCl for 1 hour in the dark at 37&#x000b0;C and subsequently neutralized with 0.1 M sodium borate (pH 8.5). The outgrowths were blocked with 10&#x00025; BSA/PBS for 10 minutes. BrdU incorporation was detected by incubation with a mouse monoclonal anti-BrdU antibody (1&#x02236;50; Alexa Fluor 594, Roche) in blocking solution for 1 hour in the dark at 37&#x000b0;C. Shown are representatives of a total of 29 outgrowths analyzed.</p><p>(2.33 MB TIF)</p></caption><media xlink:href="pone.0005034.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s004"><label>Figure S4</label><caption><p>Growth curves for mock-, control siRNA, and two Cobra1 siRNA-transfected ESCs. For measuring cell proliferation, cells were plated in triplicate at a density of 2000 cells/well in a 96-well plate. Cell proliferation was measured from day 1 to 5 using CellTiter96 Aqueous One Solution Cell proliferation assay (Promega) according to manufacturer's instructions.</p><p>(1.08 MB TIF)</p></caption><media xlink:href="pone.0005034.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s005"><label>Figure S5</label><caption><p>Gene Ontology of the microarray result from up-regulated genes in Cobra1 knockdown ESCs.</p><p>(1.33 MB TIF)</p></caption><media xlink:href="pone.0005034.s005.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s006"><label>Table S1</label><caption><p>Genes in ES cells that are up- or down-regulated by COBRA1 knockdown</p><p>(0.32 MB XLS)</p></caption><media xlink:href="pone.0005034.s006.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s007"><label>Table S2</label><caption><p>Developmental genes that are up-regulated in Cobra1 knockdown ESCs. Also shown are association of the promoter region of each gene with the three master regulators as shown by a previously published study (Boyer, L.A. et al. Cell 122: 947&#x02013;956).</p><p>(1.34 MB TIF)</p></caption><media xlink:href="pone.0005034.s007.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005034.s008"><label>Table S3</label><caption><p>Primers used in the study</p><p>(1.33 MB TIF)</p></caption><media xlink:href="pone.0005034.s008.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Drs. L. Donehower and K.S. Ravichandran for mouse strains.</p></ack><ref-list><title>References</title><ref id="pone.0005034-Surani1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Surani</surname><given-names>MA</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Hajkova</surname><given-names>P</given-names></name></person-group><year>2007</year><article-title>Genetic and epigenetic regulators of pluripotency.</article-title><source>Cell</source><volume>128</volume><fpage>747</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">17320511</pub-id></citation></ref><ref id="pone.0005034-Jaenisch1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>R</given-names></name></person-group><year>2008</year><article-title>Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.</article-title><source>Cell</source><volume>132</volume><fpage>567</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">18295576</pub-id></citation></ref><ref id="pone.0005034-Boyer1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>LA</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Cole</surname><given-names>MF</given-names></name><name><surname>Johnstone</surname><given-names>SE</given-names></name><name><surname>Levine</surname><given-names>SS</given-names></name><etal/></person-group><year>2005</year><article-title>Core transcriptional regulatory circuitry in human embryonic stem cells.</article-title><source>Cell</source><volume>122</volume><fpage>947</fpage><lpage>956</lpage><pub-id pub-id-type="pmid">16153702</pub-id></citation></ref><ref id="pone.0005034-Loh1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>YH</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Chew</surname><given-names>JL</given-names></name><name><surname>Vega</surname><given-names>VB</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><year>2006</year><article-title>The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.</article-title><source>Nat Genet</source><volume>38</volume><fpage>431</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">16518401</pub-id></citation></ref><ref id="pone.0005034-Azuara1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Azuara</surname><given-names>V</given-names></name><name><surname>Perry</surname><given-names>P</given-names></name><name><surname>Sauer</surname><given-names>S</given-names></name><name><surname>Spivakov</surname><given-names>M</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>HF</given-names></name><etal/></person-group><year>2006</year><article-title>Chromatin signatures of pluripotent cell lines.</article-title><source>Nat Cell Biol</source><volume>8</volume><fpage>532</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">16570078</pub-id></citation></ref><ref id="pone.0005034-Bernstein1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Kamal</surname><given-names>M</given-names></name><name><surname>Huebert</surname><given-names>DJ</given-names></name><etal/></person-group><year>2006</year><article-title>A bivalent chromatin structure marks key developmental genes in embryonic stem cells.</article-title><source>Cell</source><volume>125</volume><fpage>315</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">16630819</pub-id></citation></ref><ref id="pone.0005034-Guenther1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Levine</surname><given-names>SS</given-names></name><name><surname>Boyer</surname><given-names>LA</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name></person-group><year>2007</year><article-title>A chromatin landmark and transcription initiation at most promoters in human cells.</article-title><source>Cell</source><volume>130</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">17632057</pub-id></citation></ref><ref id="pone.0005034-Boyer2"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>LA</given-names></name><name><surname>Plath</surname><given-names>K</given-names></name><name><surname>Zeitlinger</surname><given-names>J</given-names></name><name><surname>Brambrink</surname><given-names>T</given-names></name><name><surname>Medeiros</surname><given-names>LA</given-names></name><etal/></person-group><year>2006</year><article-title>Polycomb complexes repress developmental regulators in murine embryonic stem cells.</article-title><source>Nature</source><volume>441</volume><fpage>349</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">16625203</pub-id></citation></ref><ref id="pone.0005034-Lee1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Jenner</surname><given-names>RG</given-names></name><name><surname>Boyer</surname><given-names>LA</given-names></name><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Levine</surname><given-names>SS</given-names></name><etal/></person-group><year>2006</year><article-title>Control of developmental regulators by Polycomb in human embryonic stem cells.</article-title><source>Cell</source><volume>125</volume><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">16630818</pub-id></citation></ref><ref id="pone.0005034-Ye1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>Y-F</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Nye</surname><given-names>AC</given-names></name><name><surname>Belmont</surname><given-names>AS</given-names></name><etal/></person-group><year>2001</year><article-title>BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.</article-title><source>J Cell Biol</source><volume>155</volume><fpage>911</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">11739404</pub-id></citation></ref><ref id="pone.0005034-Narita1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Chanarat</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex.</article-title><source>Mol Cell Biol</source><volume>23</volume><fpage>1863</fpage><lpage>1873</lpage><pub-id pub-id-type="pmid">12612062</pub-id></citation></ref><ref id="pone.0005034-Yamaguchi1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>T</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><name><surname>Furuya</surname><given-names>A</given-names></name><etal/></person-group><year>1999</year><article-title>NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation.</article-title><source>Cell</source><volume>97</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">10199401</pub-id></citation></ref><ref id="pone.0005034-Aiyar1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aiyar</surname><given-names>SE</given-names></name><name><surname>Sun</surname><given-names>J-L</given-names></name><name><surname>Blair</surname><given-names>AL</given-names></name><name><surname>Moskaluk</surname><given-names>CA</given-names></name><name><surname>Lv</surname><given-names>Y</given-names></name><etal/></person-group><year>2004</year><article-title>Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.</article-title><source>Genes &#x00026; Dev</source><volume>18</volume><fpage>2134</fpage><lpage>2146</lpage><pub-id pub-id-type="pmid">15342491</pub-id></citation></ref><ref id="pone.0005034-Wu1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C-H</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Benjamin</surname><given-names>LR</given-names></name><name><surname>Horvat-Gordon</surname><given-names>M</given-names></name><name><surname>Washinsky</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila.</article-title><source>Genes &#x00026; Dev</source><volume>17</volume><fpage>1402</fpage><lpage>1414</lpage><pub-id pub-id-type="pmid">12782658</pub-id></citation></ref><ref id="pone.0005034-Aiyar2"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aiyar</surname><given-names>SE</given-names></name><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><year>2007</year><article-title>Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells.</article-title><source>Int J Biol Sci</source><volume>3</volume><fpage>486</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">18071589</pub-id></citation></ref><ref id="pone.0005034-Gilchrist1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname><given-names>DA</given-names></name><name><surname>Nechaev</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Ghosh</surname><given-names>SK</given-names></name><name><surname>Collins</surname><given-names>JB</given-names></name><etal/></person-group><year>2008</year><article-title>NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly.</article-title><source>Genes Dev</source><volume>15</volume><fpage>1921</fpage><lpage>1933</lpage><pub-id pub-id-type="pmid">18628398</pub-id></citation></ref><ref id="pone.0005034-Narita2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>T</given-names></name><name><surname>Yung</surname><given-names>TM</given-names></name><name><surname>Yamamoto</surname><given-names>J</given-names></name><name><surname>Tsuboi</surname><given-names>Y</given-names></name><name><surname>Tanabe</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>NELF Interacts with CBC and Participates in 3&#x02032; End Processing of Replication-Dependent Histone mRNAs.</article-title><source>Mol Cell</source><volume>26</volume><fpage>349</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">17499042</pub-id></citation></ref><ref id="pone.0005034-Moynahan1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moynahan</surname><given-names>ME</given-names></name></person-group><year>2002</year><article-title>The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.</article-title><source>Oncogene</source><volume>16</volume><fpage>8994</fpage><lpage>9007</lpage><pub-id pub-id-type="pmid">12483515</pub-id></citation></ref><ref id="pone.0005034-Donehower1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donehower</surname><given-names>LA</given-names></name><name><surname>Harvey</surname><given-names>M</given-names></name><name><surname>Slagle</surname><given-names>BL</given-names></name><name><surname>McArthur</surname><given-names>MJ</given-names></name><name><surname>Montgomery</surname><given-names>CAJ</given-names></name><etal/></person-group><year>1992</year><article-title>Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.</article-title><source>Nature</source><volume>356</volume><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">1552940</pub-id></citation></ref><ref id="pone.0005034-Hoppler1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoppler</surname><given-names>S</given-names></name><name><surname>Kavanagh</surname><given-names>CL</given-names></name></person-group><year>2007</year><article-title>Wnt signalling: variety at the core.</article-title><source>J Cell Sci</source><volume>120</volume><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">17251379</pub-id></citation></ref><ref id="pone.0005034-Kim1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Barrera</surname><given-names>LO</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Qu</surname><given-names>C</given-names></name><name><surname>Singer</surname><given-names>MA</given-names></name><etal/></person-group><year>2005</year><article-title>A high-resolution map of active promoters in the human genome.</article-title><source>Nature</source><volume>436</volume><fpage>876</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">15988478</pub-id></citation></ref><ref id="pone.0005034-Muse1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muse</surname><given-names>GW</given-names></name><name><surname>Gilchrist</surname><given-names>DA</given-names></name><name><surname>Nechaev</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>JS</given-names></name><etal/></person-group><year>2007</year><article-title>RNA polymerase is poised for activation across the genome.</article-title><source>Nat Genet</source><volume>39</volume><fpage>1507</fpage><lpage>1511</lpage><pub-id pub-id-type="pmid">17994021</pub-id></citation></ref><ref id="pone.0005034-Radonjic1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radonjic</surname><given-names>M</given-names></name><name><surname>Andrau</surname><given-names>JC</given-names></name><name><surname>Lijnzaad</surname><given-names>P</given-names></name><name><surname>Kemmeren</surname><given-names>P</given-names></name><name><surname>Kockelkorn</surname><given-names>TT</given-names></name><etal/></person-group><year>2005</year><article-title>Genome-wide analyses reveal RNA polymerase II located upstream of genes poised for rapid response upon S. cerevisiae stationary phase exit.</article-title><source>Mol Cell</source><volume>18</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">15837421</pub-id></citation></ref><ref id="pone.0005034-Zeitlinger1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeitlinger</surname><given-names>J</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>JW</given-names></name><name><surname>Nechaev</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo.</article-title><source>Nat Genet</source><volume>39</volume><fpage>1512</fpage><lpage>1516</lpage><pub-id pub-id-type="pmid">17994019</pub-id></citation></ref><ref id="pone.0005034-Wada1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>T</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Ferdous</surname><given-names>A</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><etal/></person-group><year>1998</year><article-title>DSIF, a novel transcription elongation factor that regulates RNA polymeerase II processitivity, is composed of human Spt4 and Spt5 homologs.</article-title><source>Genes &#x00026; Dev</source><volume>12</volume><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">9450929</pub-id></citation></ref><ref id="pone.0005034-Sun1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Blair</surname><given-names>AL</given-names></name><name><surname>Aiyar</surname><given-names>SE</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><year>2007</year><article-title>Cofactor of BRCA1 modulates androgen-dependent transcription and alternative splicing.</article-title><source>J Steroid Biochem Mol Biol</source><volume>107</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">17659869</pub-id></citation></ref><ref id="pone.0005034-Reya1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reya</surname><given-names>T</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year>2005</year><article-title>Wnt signalling in stem cells and cancer.</article-title><source>Nature</source><volume>434</volume><fpage>843</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">15829953</pub-id></citation></ref><ref id="pone.0005034-Cole1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>MF</given-names></name><name><surname>Johnstone</surname><given-names>SE</given-names></name><name><surname>Newman</surname><given-names>JJ</given-names></name><name><surname>Kagey</surname><given-names>MH</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name></person-group><year>2008</year><article-title>Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells.</article-title><source>Genes Dev</source><volume>22</volume><fpage>746</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">18347094</pub-id></citation></ref><ref id="pone.0005034-Pereira1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>L</given-names></name><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Merrill</surname><given-names>BJ</given-names></name></person-group><year>2006</year><article-title>Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal.</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>7479</fpage><lpage>7491</lpage><pub-id pub-id-type="pmid">16894029</pub-id></citation></ref><ref id="pone.0005034-He1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Pant</surname><given-names>D</given-names></name><name><surname>Schiffmacher</surname><given-names>A</given-names></name><name><surname>Meece</surname><given-names>A</given-names></name><name><surname>Keefer</surname><given-names>CL</given-names></name></person-group><year>2008</year><article-title>Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells.</article-title><source>Stem Cells</source><volume>26</volume><fpage>842</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">18192238</pub-id></citation></ref><ref id="pone.0005034-Boiani1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boiani</surname><given-names>M</given-names></name><name><surname>Sch&#x000f6;ler</surname><given-names>HR</given-names></name></person-group><year>2005</year><article-title>Regulatory networks in embryo-derived pluripotent stem cells.</article-title><source>Nat Rev Mol Cell Biol</source><volume>6</volume><fpage>872</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">16227977</pub-id></citation></ref><ref id="pone.0005034-Dejosez1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dejosez</surname><given-names>M</given-names></name><name><surname>Krumenacker</surname><given-names>JS</given-names></name><name><surname>Zitur</surname><given-names>LJ</given-names></name><name><surname>Passeri</surname><given-names>M</given-names></name><name><surname>Chu</surname><given-names>LF</given-names></name><etal/></person-group><year>2008</year><article-title>Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells.</article-title><source>Cell</source><volume>133</volume><fpage>1162</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">18585351</pub-id></citation></ref><ref id="pone.0005034-Aida1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aida</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Wada</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>Transcriptional pausing caused by NELF plays a dual role in regulating immediate-early expression of the junB gene.</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>6094</fpage><lpage>6104</lpage><pub-id pub-id-type="pmid">16880520</pub-id></citation></ref><ref id="pone.0005034-Rodriguez1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>CI</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><name><surname>Galloway</surname><given-names>J</given-names></name><name><surname>Reynaldo</surname><given-names>S</given-names></name><name><surname>Kasper</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>High-efficiency delete mice show that FLPe is an alternative to Cre-loxP.</article-title><source>Nat Genet</source><volume>25</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">10835623</pub-id></citation></ref><ref id="pone.0005034-Lakso1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakso</surname><given-names>M</given-names></name><name><surname>Pichel</surname><given-names>JG</given-names></name><name><surname>Gorman</surname><given-names>JR</given-names></name><name><surname>Sauer</surname><given-names>B</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><etal/></person-group><year>1996</year><article-title>Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>5860</fpage><lpage>5865</lpage><pub-id pub-id-type="pmid">8650183</pub-id></citation></ref><ref id="pone.0005034-Stephens1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>LE</given-names></name><name><surname>Sutherland</surname><given-names>AE</given-names></name><name><surname>Klimanskaya</surname><given-names>IV</given-names></name><name><surname>Andrieux</surname><given-names>A</given-names></name><name><surname>Meneses</surname><given-names>J</given-names></name><etal/></person-group><year>1995</year><article-title>Deletion of b1 integrins in mice results in inner cell mass failure and peri-implantation lethality.</article-title><source>Genes Dev</source><volume>9</volume><fpage>1883</fpage><lpage>1895</lpage><pub-id pub-id-type="pmid">7544312</pub-id></citation></ref><ref id="pone.0005034-Rotureau1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotureau</surname><given-names>B</given-names></name><name><surname>Gego</surname><given-names>A</given-names></name><name><surname>Carme</surname><given-names>B</given-names></name></person-group><year>2005</year><article-title>Trypanosomatid protozoa: A simplified DNA isolation procedure. .</article-title><source>Experimental Parasitology</source><volume>111</volume><fpage>207</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">16139269</pub-id></citation></ref><ref id="pone.0005034-ORourke1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Rourke</surname><given-names>JR</given-names></name><name><surname>Georges</surname><given-names>SA</given-names></name><name><surname>Seay</surname><given-names>HR</given-names></name><name><surname>Tapscott</surname><given-names>SJ</given-names></name><name><surname>McManus</surname><given-names>MT</given-names></name><etal/></person-group><year>2007</year><article-title>Essential role for Dicer during skeletal muscle development.</article-title><source>Dev Biol</source><volume>311</volume><fpage>359</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">17936265</pub-id></citation></ref><ref id="pone.0005034-Ding1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Esteve</surname><given-names>PO</given-names></name><name><surname>Chin</surname><given-names>HG</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><etal/></person-group><year>2008</year><article-title>Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation.</article-title><source>Mol Cell</source><volume>31</volume><fpage>347</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">18691967</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>The work was supported by a grant to R.L. from the National Institutes of Health (DK064604), and predoctoral fellowships to J.S. and S.J.N. from the Department of Defense Breast Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 